Cirba SRL
Cirba reported total assets of 67,062 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Sep 2026).
The score of Cirba shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -52 % Total assets -22 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cirba's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Sep 2026
- Year ended 31 Dec 2024filed on 16 Sep 2025
- Year ended 31 Dec 2023filed on 01 Oct 2024
- Year ended 31 Dec 2022filed on 21 Sep 2023
- Year ended 31 Dec 2021filed on 14 Oct 2022
Cirba's financial analysis
- Solvency21.0%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cirba
Cirba's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0877.341.838
- VAT number
- BE0877341838
- Peppol
- Registered · 0208:0877341838 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Nov 2005
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 18 Sep 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Cirba (SRL) has been based in Ixelles since 2005, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 7,505 € and equity of 14,096 €; its revenue is not published. Its solvency stands at 21.0%, below the median of its sector (32.3%).
Companies similar to Cirba
Companies in the same business, of comparable size and area, outside its group.
- AlphaCare Wholesale of pharmaceutical and medical goods Grez-Doiceau · balance sheet 559,557 €
- Belderm Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 7,299 €
- Accord Healthcare Wholesale of pharmaceutical and medical goods Brussels · balance sheet €10.5m
- Sasmar Pharmaceuticals Wholesale of pharmaceutical and medical goods Overijse · balance sheet €3.07m
- SERB Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €159.3m
- Sanofi Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €218.9m
- Novartis Pharma Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €168.8m
- Linden API Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 12,520 €
Frequently asked questions about Cirba
What is the revenue of Cirba?
Cirba files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cirba?
In Belgium, the VAT number is the company number prefixed with BE: BE0877341838 for Cirba, if the company is VAT-registered. Its company number (CBE) is 0877.341.838.
Where is the registered office of Cirba?
According to the CBE register, the registered office of Cirba is in 1050 Ixelles.
What is the equity of Cirba?
At the close of the 2025 financial year, the equity of Cirba amounts to 14,096 €, a solvency of 21.0% of total assets.
Who manages Cirba?
The register lists 1 active mandates at Cirba. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cirba
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →